HomeTNXP • NASDAQ
add
Tonix Pharmaceuticals Holding Corp
Previous close
$0.26
Day range
$0.26 - $0.28
Year range
$0.12 - $12.48
Market cap
51.29M USD
Avg Volume
169.33M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.82M | -29.26% |
Operating expense | 16.82M | -43.48% |
Net income | -14.21M | 49.19% |
Net profit margin | -503.65 | 28.18% |
Earnings per share | -0.26 | 99.56% |
EBITDA | -15.04M | 44.63% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.23M | 308.35% |
Total assets | 94.99M | -31.80% |
Total liabilities | 20.78M | 12.62% |
Total equity | 74.21M | — |
Shares outstanding | 186.89M | — |
Price to book | 0.53 | — |
Return on assets | -47.05% | — |
Return on capital | -57.92% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -14.21M | 49.19% |
Cash from operations | -18.80M | 19.60% |
Cash from investing | -9.00K | 98.90% |
Cash from financing | 42.90M | 583.85% |
Net change in cash | 24.08M | 234.18% |
Free cash flow | -16.05M | -3.50% |
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
103
